The Top 10 Biotech Companies in USA in 2023
The United States has a booming biotech industry. Top biotech companies in USA are pioneering cutting-edge technology to develop treatments and cures for some of the world’s deadliest diseases. Companies such as Gilead Sciences, Celgene, Abbott Laboratories, Merck & Co., and Biogen have become household names in the sector.
From pharmaceutical giants to start-up biotechnology companies, this list offers a comprehensive snapshot of the current landscape of biotech development in the US today. America’s biotechnology sector has grown rapidly over recent years and these companies offer up just a few examples of the innovative strides being taken all across the nation!
The biotech industry is one of the most rapidly growing industries in the United States. In 2018, the industry was worth an estimated $115 billion, and it is projected to be worth $775 billion by 2025. With such rapid growth, it is no surprise that many biotech companies are vying for a spot on the top 10 list.
Here are the Biotech companies that are expected to be at the top of the list in 2023:
Gilead Sciences was founded in 1987 and has since become one of the leading companies in its field. Gilead Sciences is headquartered in Foster City, California. The company’s mission is to research, develop and commercialize innovative therapeutics that help patients live longer, healthier lives. Gilead Sciences is a biopharmaceutical company that focuses on developing treatments for HIV/AIDS, liver diseases, cancer, and inflammation.
Gilead Sciences currently has more than 11,000 employees worldwide, and its revenue is expected to reach $41 billion by 2022. The company’s products include treatments for HIV, hepatitis C, cancer, and other conditions. The company has been ranked first on the list of top biotech companies in the USA for several years in a row.
Biotech companies are working hard to develop new treatments and cures for a wide range of diseases. One of the leading biotech companies in USA is Celgene. Founded in 1986, Celgene is a global biopharmaceutical company that is dedicated to developing innovative therapies to treat cancer and other serious diseases. With over 6,000 employees worldwide, Celgene is one of the largest Biotech Companies in the USA.
The company’s products are available in over 70 countries and they have a strong presence in the US, Europe, and Asia. In 2017, Celgene was acquired by Bristol-Myers Squibb for $74 billion. This made it one of the largest Biotech Companies in the world. Today, Celgene has a market cap of over $100 billion and is expected to generate revenue of $22 billion by 2022.
Biogen is one of the leading biotech companies in USA, with a focus on developing treatments for neurological and autoimmune conditions. The company was founded in 1978, and its headquarter is located in Cambridge, Massachusetts. Biogen is expected to generate revenue of approximately 22 billion USD in 2022.
The company currently employs around 7,500 people. Biogen’s products include Tecfidera, which is used to treat multiple sclerosis, and Spinraza, which is used to treat spinal muscular atrophy. Biogen is also working on several clinical trials for potential new treatments for Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.
4. Regeneron Pharmaceuticals
Established in 1988, Regeneron Pharmaceuticals is one of the most successful biotechnology firms in the United States. The company’s headquarters are based out of Tarrytown, New York, and their yearly revenue for 2022 is projected to be an astounding 21.58 billion US dollars – with a staff count that has grown to 8 thousand people! Regeneron Pharmaceuticals focuses on developing treatments for various conditions including diabetes, high cholesterol, and eye diseases.
The company is known for its various products like EYLEA, Praluent, Dupixent, Libtayo, etc. which are used for the treatment of various diseases like macular degeneration, cholesterol, atopic dermatitis, etc. It has various collaborations with other companies like Sanofi, Bayer, Teva, etc. to develop new products and treatments. The company is constantly researching and developing new products to improve the quality of life of people suffering from various diseases.
5. Alexion Pharmaceuticals
Biotech companies are working hard to find treatments and cures for some of the most deadly diseases. One such company is Alexion Pharmaceuticals. Founded in 1992, Alexion is a global biopharmaceutical company headquartered in Boston, Massachusetts. In 2018, the company had revenue of $3.8 billion and today employs more than 4,000 people worldwide. Its revenue is expected to reach $17 billion by 2022. Alexion’s mission is to serve patients with rare diseases and ultra-rare disorders.
The company currently has five approved products on the market and two investigational therapies in clinical development. In addition, Alexion is working on several other potential treatments for rare diseases. With a strong commitment to patients and a track record of innovation, Alexion is poised to make a significant impact on the lives of those with rare diseases.
Since its founding in 1980, Amgen has established itself as a major force in the biotech industry. The company is committed to discovering and delivering innovative therapies that treat serious illnesses such as heart disease, arthritis, and cancer. With over forty years of experience creating breakthrough treatments, it’s no surprise that Amgen remains one of the most influential biotech companies in America today.
In terms of revenue, Amgen is expected to generate $32 billion in 2022. The company’s headquarter is located in Thousand Oaks, California and it employs around 21,000 people. Amgen’s product portfolio includes biological drugs for the treatment of various conditions such as cancer, osteoporosis, and blood disorders. Amgen is also involved in the research and development of new therapies for various other diseases.
Also Read: Top 10 AI Companies in USA in 2023
7. Illumina Inc
Founded in 1998, Illumina Inc is one of the leading biotechnology companies in the United States. With its headquarters based in San Diego, California, and 14 thousand employees as of 2019, it continues to grow its roots throughout America’s healthcare industry. The company develops and commercializes next-generation sequencing technologies for genome sequencing.
Some of Illumina’s products include sequencing by synthesis, sequencing by ligation, solid-state arrays, cluster generation instruments, and reagents among others. The company was ranked 140th on the Fortune 500 list of companies in America in the year 2018 and had a revenue of around 9.4 billion dollars in the same year. It is estimated that Illumina’s revenue will grow to around 27 billion dollars by the year 2022.
8. Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc is one of the Biotech Companies in USA, founded in 1989 by Joshua Boger and Kevin Kinsella. As of 2020, it has a market capitalization of $62.4 billion and is ranked 137th on the Fortune 500. The company’s revenue is expected to reach $13.3 billion in 2022. Vertex’s headquarter is located in Boston, Massachusetts, and it has approximately 2,700 employees worldwide.
The company’s main products are treatments for cystic fibrosis, hepatitis C, and cancer. Its most notable product is Kalydeco, which was approved by the FDA in 2012 for the treatment of cystic fibrosis. Vertex also has several other products in clinical trials, including drugs for the treatment of sickle cell disease and Duchenne muscular dystrophy.
9. US Biotest
US Biotech is a biotech company that was founded in 2002. The company headquarter is located in Jersey City, New Jersey. US Biotest focuses its efforts on discovering new therapeutics primarily through plasma-based products but also provides services to help support clinical trials. As of 2022, the company’s revenue is $1.2 billion. The company has more than 3,000 employees. The company’s product portfolio includes therapeutic proteins, monoclonal antibodies, and vaccines. The company has a strong product portfolio and a wide range of products. The company has a strong presence in the US market and is expected to grow at a rapid pace in the coming years.
10. Myriad Genetics
Myriad Genetics stands as one of the preeminent biotech companies in USA, revolutionizing the industry with its groundbreaking research and innovative solutions. They were founded in 1991 and its headquarter is located in Salt Lake City, Utah. Myriad Genetics focuses mainly on providing genetic testing services with over 3 million tests performed each year. In 2019, their revenue was $842 million and it is expected to reach $1.03 billion by 2022. As of 2018, they have 2,200 employees.
Myriad Genetics offers a wide range of products such as hereditary cancer tests, inherited cardiovascular disease tests, fertility tests, and more. They also offer genetic risk assessment services for various conditions such as Alzheimer’s disease, Parkinson’s disease, and others. Myriad Genetics is constantly expanding its business by entering into new markets and launching new products. Their goal is to provide patients with the information they need to make better-informed decisions about their health.
The biotech industry is one of the most rapidly growing industries not just in the United States but globally as well. With an estimated value of 115 Billion dollars in 2018, this number is only expected to grow exponentially, reaching 800 Billion by 2025.